Asthma impacts different people in different ways. Most people are able to control their asthma with regular use of their controller medication and using their reliever medication when necessary. However, for many it can be difficult to recognize when their asthma is not controlled. When asthma is well-controlled, you will experience little to no asthma symptoms.
The FRI deposition profiles highlight that the MDI/ AeroChamber Plus* Flow Vu* VHC system delivered an appreciably greater percentage of drug to the lung region than either of the two DPIs.
The influence of inhalation flow profile was less with the MDI/VHC system and differed between the two DPIs.
The prototype AeroChamber2go* spacer device was preferred by patients compared to the A2A† spacer and provides a good option for patients currently using the Metered Dose Inhaler without a spacer while on-the-go.
It is our pleasure to announce that in honour of the late Mitchell Baran, the founder and leader of the Trudell Medical Group of Companies, the City of London has renamed the portion of Third Street that two of the Trudell Companies are located to “Baransway Drive”.
The back-to-school season can be an exciting time for both kids and parents, but did you know that this time of year has been linked to a considerable increase in hospitalizations for children with asthma? This phenomenon is referred to as the September Asthma Spike, where hospitalizations begin to increase at the start of the school year until they peak during the third week of September.1
May 1, 2018: Today is the 20th annual World Asthma Day, an event held each May to raise awareness of Asthma worldwide. World Asthma Day is organized by the Global Initiative for Asthma, or GINA (www.ginasthma.org), a World Health Organization collaborative and 501(c)3 organization founded in 1993.
More consistent dose delivery was achieved with the breath actuated technology rather than breath enhanced. Delivering medication only when the patient inhales would result in more stable therapy if I:E ratio was to change with disease< progression or if the patient took breaks to talk during treatment.
Bronchiectasis is a chronic, progressive lung condition affecting infants, children and adults. While the global prevalence of bronchiectasis is not accurately known,1 there is a growing awareness of the disease.2
Nous vous invitons à participer à la plus récente séance « Demandez à l’expert » avec Linda Perron, une inhalothérapeute spécialisée en MPOC au Québec. Elle fournira des conseils sur la meilleure façon de prendre en charge la MPOC, sur l’importance du dégagement du mucus et des médicaments par inhalation, ainsi que sur l’impact que la COVID-19 peut avoir sur la MPOC.
Durant le webinaire, on répondra à des questions comme les suivantes :
